| TIGIT expressing CD4+ T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia K Catakovic, FJ Gassner, C Ratswohl, N Zaborsky, S Rebhandl, ... Oncoimmunology 7 (1), e1371399, 2018 | 85 | 2018 |
| CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity JC Gutjahr, E Bayer, X Yu, JM Laufer, JP Höpner, S Tesanovic, ... haematologica 106 (8), 2102, 2020 | 34 | 2020 |
| Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia JC Gutjahr, E Szenes, L Tschech, D Asslaber, M Schlederer, S Roos, ... Blood, The Journal of the American Society of Hematology 131 (12), 1337-1349, 2018 | 32 | 2018 |
| SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod L Meyer-Arndt, J Braun, F Fauchere, K Vanshylla, L Loyal, L Henze, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (9), 960-971, 2022 | 28 | 2022 |
| Discriminating promiscuous from target‐specific autoantibodies in COVID‐19 M Lebedin, CV García, L Spatt, C Ratswohl, C Thibeault, L Ostendorf, ... European Journal of Immunology 53 (5), 2250210, 2023 | 17 | 2023 |
| Different classes of genomic inserts contribute to human antibody diversity M Lebedin, M Foglierini, S Khorkova, C Vázquez García, C Ratswohl, ... Proceedings of the National Academy of Sciences 119 (36), e2205470119, 2022 | 13 | 2022 |
| A design strategy to generate a SARS‐CoV‐2 RBD vaccine that abrogates ACE2 binding and improves neutralizing antibody responses C Ratswohl, C Vázquez García, AW Ahmad, H Gonschior, M Lebedin, ... European Journal of Immunology 53 (10), 2350408, 2023 | 2 | 2023 |
| Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses M Lebedin, C Ratswohl, A Garg, M Schips, CV García, L Spatt, ... Iscience 27 (3), 2024 | 1 | 2024 |
| SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular 3 immune responses in multiple sclerosis patients receiving 4 fingolimod 5 L Meyer-Arndt, J Braun, F Fauchere, K Vanshylla, L Loyal, CR Rosa, ... J Neurol Neurosurg Psychiatry 960, 93, 2022 | 1 | 2022 |
| NEW CORONAVIRUS VACCINE AND METHOD FOR DESIGNING AND OBTAINING A VIRUS VACCINE RK De La, M Lebedin, C Ratswohl, C Vázquez García, C Silvis, K Eyer, ... US Patent App. 18/687,263, 2024 | | 2024 |
| New coronavirus vaccine and method for designing and obtaining a virus vaccine K de la Rosa, M Lebedin, C Ratswohl, C Vazquez Garcia, C Silvis, K Eyer, ... | | 2024 |
| A novel strategy of structure-guided vaccine design to enhance the availability of immunogens C Ratswohl, CV Garcia, AUW Ahmad, M Lebedin, C Silvis, L Spatt, ... EUROPEAN JOURNAL OF IMMUNOLOGY 52, 173-173, 2022 | | 2022 |
| Dynamic analysis of cytoplasmic calcium and its role in regulating the metabolic activity of plasma cells C Ulbricht, R Leben, L Schuessler, Y Cao, AF Fiedler, C Ratswohl, ... EUROPEAN JOURNAL OF IMMUNOLOGY 52, 143-143, 2022 | | 2022 |
| BIBAX: a novel structure-guided approach to improve vaccine safety and efficacy C Ratswohl, M Lebedin, CV Garcia, C Silvis, L Spatt, AUW Ahmad, ... EUROPEAN JOURNAL OF IMMUNOLOGY 52, 98-99, 2022 | | 2022 |
